The compounded bioidentical hormone industry needs major changes in oversight to keep consumers safe.
Jill Liss, MD
Advertisement
Assistant professor of obstetrics and gynecology at the University of Colorado Denver School of Medicine; OB/GYN Clerkship Director
Articles by Jill Liss, MD
Advertisement
Latest Updated Articles
Stand firm with sciencePublished: October 5th 2020 | Updated:
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Early estrogen use linked to lower disease risks
2
FDA approves elinzanetant (Lynkuet) for vasomotor menopausal symptoms
3
Elinzanetant demonstrates favorable safety profile in menopausal women, with James A. Simon, MD
4
Cynthia Stuenkel, MD, talks evaluating and managing primary ovarian insufficiency
5
